Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2010 - 2026)

Rigel Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$145000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 114.01% year-over-year to -$145000.0 in Q1 2026; TTM through Mar 2026 was -$456000.0, a 189.24% decrease from a year earlier, with the FY2025 full-year figure at $724000.0, up 204.62% from the prior year.
• Other Working Capital Changes eased to -$145000.0 in Q1 2026 per RIGL's latest filing, from -$141000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $13.2 million in Q1 2025 and bottomed at -$6.6 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is $1.4 million (2024), against an average of $1.0 million.
• Across the five-year window, Other Working Capital Changes sank 447.13% in 2023 and surged 716.07% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$174000.0 in 2022, then climbed by 6.9% to -$162000.0 in 2023, then fell by 11.73% to -$181000.0 in 2024, then gained by 22.1% to -$141000.0 in 2025, then decreased by 2.84% to -$145000.0 in 2026.
• Per Business Quant, the three latest RIGL Other Working Capital Changes figures stand at -$145000.0 (Q1 2026), -$141000.0 (Q4 2025), and -$81000.0 (Q3 2025).